The percentage of CD8+ T cells, on the other hand, showed positive correlations with Ann Arbor stage, IPI score, LDH, β2-microglobulin, and age, suggesting that the percentage of CD8+ T cell counts may play an important role in the progression or treatment response of DLBCL. Here, CD8A is linked to diffuse large B-cell lymphoma.